0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$7,950USDGBP
From
EUR$7,950USDGBP
From
EUR$7,950USDGBP
From
EUR$7,950USDGBP
From
EUR$7,950USDGBP
From
EUR$7,950USDGBP
From
EUR$7,950USDGBP
From
EUR$7,950USDGBP
REMICADE Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

REMICADE Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
SKYRIZI Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SKYRIZI Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
EUR$3,250USDGBP
TREMFYA Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

TREMFYA Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
EUR$3,250USDGBP
HUMIRA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

HUMIRA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
STELARA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

STELARA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
Nemolizumab Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Nemolizumab Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
Difamilast Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Difamilast Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
Abrocitinib Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Abrocitinib Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
OPZELURA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

OPZELURA Market Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
Hidradenitis Suppurativa (HS) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Hidradenitis Suppurativa (HS) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 95 Pages
  • Global
From
EUR$3,950USDGBP
Contact Dermatitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Contact Dermatitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Chronic Inducible Urticaria Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Inducible Urticaria Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more